FDA adds high-grade papillary-only bladder cancer to Anktiva's indication on Oct. 14, before ImmunityBio's Jan. 6, 2027 ...

Strive proposes five million preferred shares with a 15 per cent dividend, implying US$75 million in annual accruals if the ...

Pharming reports a 26.4 per cent mean spleen-volume reduction in its 13-person leniolisib trial, with a separate CVID readout ...

Rio Tinto retained copper guidance of 800,000 to 870,000 tonnes as Oyu Tolgoi output rose 27 per cent in the third quarter.

Thor Explorations poured 15,515 gold ounces in Q3 2026 after heavy rainfall and kept cost guidance and its C$0.0125 quarterly ...

Grange Resources approves A$287 million for Savage River underground development, targeting pellet supply through 2035 and ...

Regis Resources says the Federal Court ruled a heritage declaration invalid at McPhillamys, which holds 1.89 million ounces ...

The NSW Court of Appeal dismisses Cosette's challenge over a terminated A$7.40-a-share deal; Mayne Pharma continues pursuing ...

Olympus says an Oct. 7 FDA warning covers six facilities, plans a response within 15 business days of receipt and reports no ...

Liquidia agrees to US$380.7M in settlement payments, preserving YUTREPIA sales for PAH while ending PH-ILD promotion.

Xtra-Gold reports 1,404,900 indicated gold ounces at Kibi, including 156,100 ounces in a buffer zone awaiting formal lease ...

Paladin Energy reports 1.00 million pounds of September-quarter uranium output, higher unit costs and US$209 million in cash ...